상처 치료 및 첨단 드레싱 기술 시장 예측(-2034년) : 제품 유형, 상처 종류, 유통 채널, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Wound Care & Advanced Dressing Technologies Market is accounted for $13.4 billion in 2026 and is expected to reach $21.9 billion by 2034 growing at a CAGR of 6.3% during the forecast period. Wound Care & Advanced Dressing Technologies cover specialized solutions that safeguard wounds, facilitate tissue repair, control wound fluid, reduce infection risks, and create suitable healing conditions. The market includes hydrocolloid, hydrogel, foam, alginate, antimicrobial, collagen, and digitally enabled dressing technologies. These advanced solutions are increasingly used for managing chronic and surgical wounds, burns, diabetic ulcers, and pressure-related injuries. Their development focuses on accelerating healing, improving patient comfort, supporting infection prevention, and enabling more effective wound management in hospitals, clinics, and other healthcare environments.

According to the International Diabetes Federation (IDF), 589 million adults aged 20-79 were living with diabetes globally in 2024, representing 11.1% of adults in this age group. The IDF projects this number to reach 852.5 million by 2050. Diabetes is closely associated with foot ulcers and other chronic wounds, supporting the need for wound-care products and advanced dressing technologies.

Market Dynamics:

Driver:

Rising prevalence of chronic wounds

The growing burden of chronic wounds is supporting demand for Wound Care & Advanced Dressing Technologies. Rising rates of diabetes, obesity, vascular diseases, and limited mobility are increasing the occurrence of diabetic ulcers, venous wounds, and pressure injuries. Because these conditions frequently require extended treatment, healthcare facilities are turning to specialized dressings that regulate moisture, manage wound exudate, protect against infection, and support tissue repair. Increasing utilization of foam, hydrocolloid, alginate, antimicrobial, and collagen dressings is therefore contributing to market expansion.

Restraint:

High cost of advanced wound care products

The relatively high price of advanced wound care solutions can limit their widespread adoption compared with traditional dressings. Antimicrobial products, collagen dressings, specialized foams, and other technologically advanced solutions may increase treatment expenses for healthcare providers and patients. Inadequate reimbursement and restricted hospital budgets can create additional barriers to adoption. Consequently, healthcare facilities operating under financial pressure may continue relying on conventional dressings, particularly when treating numerous patients or managing chronic wounds that require extended periods of care.

Opportunity:

Expansion of home-based wound care

Growing adoption of home-based wound management offers significant opportunities for advanced dressing technologies. Greater use of outpatient services, increasing numbers of older adults, persistent chronic wounds, and efforts to shorten hospital stays are shifting some wound treatment toward patients' homes. Specialized dressings designed for convenient application, patient comfort, moisture balance, and exudate control can facilitate this transition. In addition, telehealth consultations and remote wound monitoring can help clinicians supervise treatment, creating opportunities for broader adoption of advanced wound care solutions in home healthcare.

Threat:

Competition from conventional and alternative treatment methods

Advanced wound care technologies face competition from established conventional products and alternative treatment methods. Basic gauze, bandages, and traditional dressings continue to be commonly used because they are accessible and generally more affordable, particularly in budget-constrained healthcare settings. Other approaches, including negative pressure wound therapy, biological materials, topical therapies, and specialized interventions, also compete for clinical adoption and healthcare expenditure. Established treatment habits and pricing pressures can consequently reduce the pace at which healthcare providers shift toward newer advanced dressing solutions.

Covid-19 Impact:

COVID-19 significantly affected the Wound Care & Advanced Dressing Technologies Market through postponed surgeries, fewer routine clinical visits, and the reallocation of medical resources toward pandemic response. Manufacturing and distribution networks also experienced disruptions because of transportation restrictions and supply-chain challenges. Nevertheless, wound care remained necessary for chronic conditions, injuries, and patients requiring continued treatment. Growing use of telemedicine and home healthcare created additional methods for wound monitoring and management, helping the market recover progressively as healthcare facilities restored regular services.

The advanced wound dressings segment is expected to be the largest during the forecast period

The advanced wound dressings segment is expected to account for the largest market share during the forecast period because they offer versatile solutions for managing different types of wounds and clinical requirements. Their functions include maintaining appropriate moisture levels, controlling wound fluid, reducing infection risks, and supporting tissue repair. These dressings are widely utilized for chronic and surgical wounds, burns, diabetic ulcers, and pressure injuries. A broad range of specialized formats, combined with ongoing technological improvements, supports their continued use across hospitals, outpatient facilities, and home-based wound care environments.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate as wound management increasingly shifts toward convenient and patient-focused treatment at home. Rising chronic wound prevalence, population aging, reduced hospital stays, and the need for economical care are supporting this transition. Advanced wound dressings enable effective home treatment through moisture regulation, exudate control, infection protection, and healing support. Additionally, wider adoption of telehealth services and remote monitoring technologies is improving clinical supervision, creating favorable conditions for greater use of advanced wound care products in home healthcare.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its developed healthcare systems, widespread use of innovative medical solutions, and considerable need for chronic wound treatment. The region experiences substantial demand associated with diabetes, vascular disorders, pressure injuries, and other complex wounds. Broad access to specialized wound-care facilities, advanced therapies, and established treatment practices strengthens adoption. Published research identifies North America as the largest regional market for advanced wound-care products and technologies worldwide.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving healthcare systems, increased surgical procedures, rising chronic wound cases, and greater healthcare investment. Markets such as China, India, and Japan are supporting regional development through better healthcare accessibility and increasing utilization of advanced wound treatment solutions. Population aging and the growing prevalence of chronic illnesses are further creating demand for specialized products. Continued technological innovation is also helping expand the adoption of advanced wound care technologies throughout the region.

Key players in the market

Some of the key players in Wound Care & Advanced Dressing Technologies Market include Smith+Nephew, Molnlycke Health Care, ConvaTec Group, Coloplast, Solventum, Medline Industries, Cardinal Health, Integra LifeSciences, B. Braun, PAUL HARTMANN, Advanced Medical Solutions, Lohmann & Rauscher, Urgo Medical, Organogenesis, MiMedx Group, DeRoyal Industries, Winner Medical and Hollister Incorporated.

Key Developments:

In June 2025, Smith+Nephew announce a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wrist procedures.

In March 2025, Convatec is excited to announce its global collaboration with the Wound, Ostomy, and Continence Nurses Society(TM) (WOCN(R)), the largest and most recognised professional nursing community dedicated to advancing the practice and delivery of expert healthcare to individuals with wound, ostomy, and continence care needs.

Product Types Covered:

• Traditional Wound Care Products
• Advanced Wound Dressings
• Wound Therapy Devices
• Active & Bioactive Wound Care

Wound Types Covered:

• Chronic Wounds
• Acute Wounds

Distribution Channels Covered:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

End Users Covered:

• Hospitals
• Clinics
• Home Healthcare
• Ambulatory Surgical Centers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Wound Care & Advanced Dressing Technologies Market, By Product Type

• 5.1 Traditional Wound Care Products
• 5.2 Advanced Wound Dressings
• 5.3 Wound Therapy Devices
• 5.4 Active & Bioactive Wound Care

6 Global Wound Care & Advanced Dressing Technologies Market, By Wound Type

• 6.1 Chronic Wounds
• 6.2 Acute Wounds

7 Global Wound Care & Advanced Dressing Technologies Market, By Distribution Channel

• 7.1 Hospital Pharmacies
• 7.2 Retail Pharmacies
• 7.3 Online Pharmacies

8 Global Wound Care & Advanced Dressing Technologies Market, By End User

• 8.1 Hospitals
• 8.2 Clinics
• 8.3 Home Healthcare
• 8.4 Ambulatory Surgical Centers

9 Global Wound Care & Advanced Dressing Technologies Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 Smith+Nephew
• 12.2 Molnlycke Health Care
• 12.3 ConvaTec Group
• 12.4 Coloplast
• 12.5 Solventum
• 12.6 Medline Industries
• 12.7 Cardinal Health
• 12.8 Integra LifeSciences
• 12.9 B. Braun
• 12.10 PAUL HARTMANN
• 12.11 Advanced Medical Solutions
• 12.12 Lohmann & Rauscher
• 12.13 Urgo Medical
• 12.14 Organogenesis
• 12.15 MiMedx Group
• 12.16 DeRoyal Industries
• 12.17 Winner Medical
• 12.18 Hollister Incorporated